IUGNF / Imugene granted patent for gastric cancer therapy in major oncology market

Imugene Ltd (ASX:IMU, OTC:IUGNF) (Imugene Ltd (ASX:IMU, OTC:IUGNF), Imugene Ltd (ASX:IMU, OTC:IUGNF)) has signed up a chief financial officer (CFO) in more_horizontal

Imugene Ltd (ASX:IMU, OTC:IUGNF) has appointed Dr Steven Cha as its chief medical officer (CMO) and a member of its executive management team. Dr Cha more_horizontal

Imugene Ltd (ASX:IMU, OTC:IUGNF) has appointed Dr Steven Cha as its chief medical officer (CMO) and a member of its executive management team. Dr Cha more_horizontal

Imugene Ltd (ASX:IMU, OTC:IUGNF) has appointed Dr Steven Cha as its chief medical officer (CMO) and a member of its executive management team. Dr Cha more_horizontal

Imugene Ltd (ASX:IMU, OTC:IUGNF) has received a notice of grant from the Japanese Patent Office for Patent Application number 2019-507161 which protec more_horizontal

Imugene Ltd (ASX:IMU, OTC:IUGNF) has received a notice of grant from the Japanese Patent Office for Patent Application number 2019-507161 which protec more_horizontal

Imugene Ltd (ASX:IMU, OTC:IUGNF) has received a notice of grant from the Japanese Patent Office for Patent Application number 2019-507161 which protec more_horizontal

Imugene Ltd (ASX:IMU, OTC:IUGNF) has opened the doors to a large and lucrative market for immuno-oncology by securing a Notice of Grant from the Euro more_horizontal